VEEV Veeva Systems Inc Class A

Veeva R&D Summit to Feature Six of the Top 25 Largest Pharmaceutical Companies and Leading Biotechs

Veeva Systems today announced details for the 2016 Veeva Global R&D Summit. The third annual event will be held from October 17-19, 2016 at the Loews Philadelphia Hotel and features speakers from the world’s leading pharmaceutical companies and biotechs, including Abbvie, Eli Lilly and Company, and Merck.

This year’s event will explore how unified application suites are transforming business processes in clinical, regulatory, and quality. Over two days there will be nearly 50 breakout sessions with in-depth best practices and case studies in handling challenges such as managing regulatory events, ensuring inspection-readiness, and working compliantly with partners.

More than 35 speakers from leading life sciences companies are scheduled to speak, including Advanced Clinical, Alimera Sciences, bluebird bio, C.R. Bard, Dimension Therapeutics, inVentiv Health, Karyopharm Therapeutics, Inc., MacroGenics, The Medicines Company, Regeneron, REGENXBIO Inc., TherapeuticsMD, United Therapeutics, and ZS Pharma, among others.

CEO and co-founder, Peter Gassner, will open the Veeva R&D Summit with a keynote address on Tuesday, October 18, highlighting the evolution of the Veeva Vault platform and Veeva’s technology vision for the future of enterprise content management.

Following Gassner, three of the top 25 largest pharmaceutical companies will discuss a range of topics, including compliant collaboration in quality operations, standardizing content and data management across the enterprise, and transforming regulatory operations.

Jen Goldsmith, senior vice president of Veeva Vault, and Avril England, general manager of Veeva Vault, will conclude the keynote highlighting how customers are managing both content and data with unified suites of applications for clinical, quality, and regulatory that work together seamlessly for better visibility and control throughout the enterprise.

The 2016 Veeva Global R&D Summit is sponsored by Accenture, Amazon Web Services, Cognizant, Deloitte, DocuSign, Epista Life Science, Extedo, HighPoint Solutions, Lorenz Life Sciences Group, LPW Training Services, Paragon Solutions, UL EduNeering, and Valiance Partners.

Registration for the event is complimentary for Veeva customers and invited guests. Learn more, register, and view the full agenda at veeva.com/R&DSummit.

Additional Information

Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems

Follow us @veevasystems on Twitter: twitter.com/veevasystems

Like Veeva on Facebook: facebook.com/veevasystems

About Veeva Systems

Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 450 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit veeva.com.

® 2016 Veeva Systems Inc. All rights reserved. Veeva and the Veeva logo are trademarks of Veeva Systems Inc. Veeva Systems Inc. owns other registered and unregistered trademarks.

EN
28/09/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Veeva Systems Inc Class A

Veeva Systems Inc: 1 director

A director at Veeva Systems Inc sold 3,882 shares at 216.830USD and the significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: February 11, 2023

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: February 8, 2023

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ResearchPool Subscriptions

Get the most out of your insights

Get in touch